{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T10:10:11Z","timestamp":1764238211143},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Maternal characteristics like medical history and health-related risk factors can influence the incidence of pregnancy outcomes and pregnancy-related events of interest (EIs). Data on the incidence of these endpoints in low-risk pregnant women are needed for appropriate external safety comparisons in maternal immunization trials. To address this need, this study estimated the incidence proportions of pregnancy outcomes and pregnancy-related EIs in different pregnancy cohorts (including low-risk pregnancies) in England, contained in the Clinical Practice Research Datalink (CPRD) Pregnancy Register linked to Hospital Episode Statistics (HES) between 2005 and 2017.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The incidence proportions of 7 pregnancy outcomes and 15 EIs were calculated for: (1) all pregnancies (AP) represented in the CPRD Pregnancy Register linked to HES (AP cohort;<jats:italic>N<\/jats:italic>\u2009=\u2009298 155), (2) all pregnancies with a gestational age (GA)\u2009\u2265\u200924\u00a0weeks (AP24+ cohort;<jats:italic>N<\/jats:italic>\u2009=\u2009208 328), and (3) low-risk pregnancies (LR cohort;<jats:italic>N<\/jats:italic>\u2009=\u2009137 932) with a GA\u2009\u2265\u200924\u00a0weeks and no diagnosis of predefined high-risk medical conditions until 24\u00a0weeks GA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Miscarriage was the most common adverse pregnancy outcome in the AP cohort (1 379.5 per 10 000 pregnancies) but could not be assessed in the other cohorts because these only included pregnancies with a GA\u2009\u2265\u200924\u00a0weeks, and miscarriages with GA\u2009\u2265\u200924\u00a0weeks were reclassified as stillbirths. Preterm delivery (&lt;\u200937\u00a0weeks GA) was the most common adverse pregnancy outcome in the AP24+\u2009and LR cohorts (742.9 and 680.0 per 10 000 pregnancies, respectively). Focusing on the cohorts with a GA\u2009\u2265\u200924\u00a0weeks, the most common pregnancy-related EIs in the AP24+\u2009and LR cohorts were fetal\/perinatal distress or asphyxia (1 824.3 and 1 833.0 per 10 000 pregnancies), vaginal\/intrauterine hemorrhage (799.2 and 729.0 per 10 000 pregnancies), and labor protraction\/arrest disorders (752.4 and 774.5 per 10 000 pregnancies).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study generated incidence proportions of pregnancy outcomes and pregnancy-related EIs from the CPRD for different pregnancy cohorts, including low-risk pregnancies. The reported incidence proportions of pregnancy outcomes and pregnancy-related EIs are largely consistent with external estimates. These results may facilitate the interpretation of safety data from maternal immunization trials and the safety monitoring of maternal vaccines. They may also be of interest for any intervention studied in populations of pregnant women.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12884-022-04769-x","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T09:02:46Z","timestamp":1654074166000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Facilitating safety evaluation in maternal immunization trials: a retrospective cohort study to assess pregnancy outcomes and events of interest in low-risk pregnancies in England"],"prefix":"10.1186","volume":"22","author":[{"given":"Megan","family":"Riley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra","family":"Lambrelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ouzama","family":"Henry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Sawalhi-Leckenby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Donaldson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia K.","family":"Stoszek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"issue":"4","key":"4769_CR1","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1080\/21645515.2015.1127485","volume":"12","author":"H Marshall","year":"2016","unstructured":"Marshall H, McMillan M, Andrews RM, Macartney K, Edwards K. Vaccines in pregnancy: The dual benefit for pregnant women and infants. Hum Vaccin Immunother. 2016;12(4):848\u201356.","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"4769_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/07853890.2017.1421320","volume":"50","author":"I Vojtek","year":"2018","unstructured":"Vojtek I, Dieussaert I, Doherty TM, Franck V, Hanssens L, Miller J, et al. Maternal immunization: where are we now and how to move forward? Ann Med. 2018;50(3):193\u2013208.","journal-title":"Ann Med"},{"issue":"5","key":"4769_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000441","volume":"8","author":"SB Omer","year":"2011","unstructured":"Omer SB, Goodman D, Steinhoff MC, Rochat R, Klugman KP, Stoll BJ, et al. Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLoS Med. 2011;8(5): e1000441.","journal-title":"PLoS Med"},{"issue":"1","key":"4769_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/AOG.0000000000000581","volume":"125","author":"GK Swamy","year":"2015","unstructured":"Swamy GK, Heine RP. Vaccinations for pregnant women. Obstet Gynecol. 2015;125(1):212\u201326.","journal-title":"Obstet Gynecol"},{"issue":"47","key":"4769_CR5","first-page":"461","volume":"87","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. Vaccines against influenza WHO position paper - November 2012. Wkly Epidemiol Rec. 2012;87(47):461\u201376.","journal-title":"Wkly Epidemiol Rec"},{"issue":"35","key":"4769_CR6","first-page":"433","volume":"90","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. Pertussis vaccines: WHO position paper - September 2015. Wkly Epidemiol Rec. 2015;90(35):433\u201358.","journal-title":"Wkly Epidemiol Rec"},{"issue":"6","key":"4769_CR7","first-page":"53","volume":"92","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Tetanus vaccines: WHO position paper \u2013 February 2017. Wkly Epidemiol Rec. 2017;92(6):53\u201376.","journal-title":"Wkly Epidemiol Rec"},{"key":"4769_CR8","unstructured":"National Health Service. NHS vaccinations and when to have them. https:\/\/www.nhs.uk\/conditions\/vaccinations\/nhs-vaccinations-and-when-to-have-them\/. Accessed 9 June 2021."},{"key":"4769_CR9","unstructured":"Center for Disease Control and Prevention. Vaccines During and After Pregnancy. https:\/\/www.cdc.gov\/vaccines\/pregnancy\/vacc-during-after.html. Accessed 9 June 2021."},{"key":"4769_CR10","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3389\/fimmu.2018.00436","volume":"9","author":"FM Munoz","year":"2018","unstructured":"Munoz FM. Current challenges and achievements in maternal immunization research. Front Immunol. 2018;9:436.","journal-title":"Front Immunol"},{"issue":"13","key":"4769_CR11","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1056\/NEJMra1509044","volume":"376","author":"SB Omer","year":"2017","unstructured":"Omer SB. Maternal immunization. N Engl J Med. 2017;376(13):1256\u201367.","journal-title":"N Engl J Med"},{"issue":"6","key":"4769_CR12","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41372-020-0668-3","volume":"40","author":"C Engmann","year":"2020","unstructured":"Engmann C, Fleming JA, Khan S, Innis BL, Smith JM, Hombach J, et al. Closer and closer? Maternal immunization: current promise, future horizons. J Perinatol. 2020;40(6):844\u201357.","journal-title":"J Perinatol"},{"issue":"7","key":"4769_CR13","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1016\/S1473-3099(17)30232-3","volume":"17","author":"PT Heath","year":"2017","unstructured":"Heath PT, Culley FJ, Jones CE, Kampmann B, Le Doare K, Nunes MC, et al. Group B streptococcus and respiratory syncytial virus immunisation during pregnancy: a landscape analysis. Lancet Infect Dis. 2017;17(7):e223\u201334.","journal-title":"Lancet Infect Dis"},{"issue":"suppl_2","key":"4769_CR14","doi-asserted-by":"publisher","first-page":"S160","DOI":"10.1093\/cid\/cix656","volume":"65","author":"L Madrid","year":"2017","unstructured":"Madrid L, Seale AC, Kohli-Lynch M, Edmond KM, Lawn JE, Heath PT, et al. Infant group B streptococcal disease incidence and serotypes worldwide: Systematic review and meta-analyses. Clin Infect Dis. 2017;65(suppl_2):S160-72.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"4769_CR15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/irv.12443","volume":"11","author":"RM Reeves","year":"2017","unstructured":"Reeves RM, Hardelid P, Gilbert R, Warburton F, Ellis J, Pebody RG. Estimating the burden of respiratory syncytial virus (RSV) on respiratory hospital admissions in children less than five years of age in England, 2007\u20132012. Influenza Other Respir Viruses. 2017;11(2):122\u20139.","journal-title":"Influenza Other Respir Viruses"},{"issue":"10098","key":"4769_CR16","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","volume":"390","author":"T Shi","year":"2017","unstructured":"Shi T, McAllister DA, O\u2019Brien KL, Simoes EAF, Madhi SA, Gessner BD, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390(10098):946\u201358.","journal-title":"Lancet"},{"issue":"18","key":"4769_CR17","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1001\/jama.2019.4981","volume":"321","author":"AS Alexopoulos","year":"2019","unstructured":"Alexopoulos AS, Blair R, Peters AL. Management of preexisting diabetes in pregnancy: A review. JAMA. 2019;321(18):1811\u20139.","journal-title":"JAMA"},{"key":"4769_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g2301","volume":"348","author":"K Bramham","year":"2014","unstructured":"Bramham K, Parnell B, Nelson-Piercy C, Seed PT, Poston L, Chappell LC. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ. 2014;348: g2301.","journal-title":"BMJ"},{"issue":"1","key":"4769_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191002","volume":"13","author":"F Fuchs","year":"2018","unstructured":"Fuchs F, Monet B, Ducruet T, Chaillet N, Audibert F. Effect of maternal age on the risk of preterm birth: A large cohort study. PLoS ONE. 2018;13(1): e0191002.","journal-title":"PLoS ONE"},{"issue":"2","key":"4769_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056583","volume":"8","author":"LC Kenny","year":"2013","unstructured":"Kenny LC, Lavender T, McNamee R, O\u2019Neill SM, Mills T, Khashan AS. Advanced maternal age and adverse pregnancy outcome: evidence from a large contemporary cohort. PLoS ONE. 2013;8(2): e56583.","journal-title":"PLoS ONE"},{"issue":"10","key":"4769_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186287","volume":"12","author":"SC Lean","year":"2017","unstructured":"Lean SC, Derricott H, Jones RL, Heazell AEP. Advanced maternal age and adverse pregnancy outcomes: A systematic review and meta-analysis. PLoS ONE. 2017;12(10): e0186287.","journal-title":"PLoS ONE"},{"issue":"8","key":"4769_CR22","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1055\/s-0036-1571318","volume":"33","author":"MG Leon","year":"2016","unstructured":"Leon MG, Moussa HN, Longo M, Pedroza C, Haidar ZA, Mendez-Figueroa H, et al. Rate of gestational diabetes mellitus and pregnancy outcomes in patients with chronic hypertension. Am J Perinatol. 2016;33(8):745\u201350.","journal-title":"Am J Perinatol"},{"issue":"2","key":"4769_CR23","first-page":"E95","volume":"56","author":"A Lelong","year":"2015","unstructured":"Lelong A, Jiroff L, Blanquet M, Mourgues C, Leymarie MC, Gerbaud L, et al. Is individual social deprivation associated with adverse perinatal outcomes? Results of a French multicentre cross-sectional survey. J Prev Med Hyg. 2015;56(2):E95\u2013101.","journal-title":"J Prev Med Hyg"},{"key":"4769_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c6654","volume":"341","author":"LK Smith","year":"2010","unstructured":"Smith LK, Manktelow BN, Draper ES, Springett A, Field DJ. Nature of socioeconomic inequalities in neonatal mortality: population based study. BMJ. 2010;341: c6654.","journal-title":"BMJ"},{"issue":"8","key":"4769_CR25","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/aogs.12430","volume":"93","author":"AA Vos","year":"2014","unstructured":"Vos AA, Posthumus AG, Bonsel GJ, Steegers EA, Denktas S. Deprived neighborhoods and adverse perinatal outcome: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2014;93(8):727\u201340.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"4769_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/AOG.0000000000001190","volume":"127","author":"GG Donders","year":"2016","unstructured":"Donders GG, Halperin SA, Devlieger R, Baker S, Forte P, Wittke F, et al. Maternal immunization with an investigational trivalent group B streptococcal vaccine: A randomized controlled trial. Obstet Gynecol. 2016;127(2):213\u201321.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"4769_CR27","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/S1473-3099(15)00484-3","volume":"16","author":"RS Heyderman","year":"2016","unstructured":"Heyderman RS, Madhi SA, French N, Cutland C, Ngwira B, Kayambo D, et al. Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial. Lancet Infect Dis. 2016;16(5):546\u201355.","journal-title":"Lancet Infect Dis"},{"issue":"44","key":"4769_CR28","doi-asserted-by":"publisher","first-page":"6930","DOI":"10.1016\/j.vaccine.2020.08.056","volume":"38","author":"GK Swamy","year":"2020","unstructured":"Swamy GK, Metz TD, Edwards KM, Soper DE, Beigi RH, Campbell JD, et al. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in pregnant women and their infants: Results from a randomized placebo-controlled phase II trial. Vaccine. 2020;38(44):6930\u201340.","journal-title":"Vaccine"},{"issue":"7","key":"4769_CR29","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/pds.4811","volume":"28","author":"C Minassian","year":"2019","unstructured":"Minassian C, Williams R, Meeraus WH, Smeeth L, Campbell OMR, Thomas SL. Methods to generate and validate a Pregnancy Register in the UK Clinical Practice Research Datalink primary care database. Pharmacoepidemiol Drug Saf. 2019;28(7):923\u201333.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"4769_CR30","unstructured":"Clinical Practice Research Datalink (CPRD). CPRD linked data. https:\/\/www.cprd.com\/linked-data. Accessed 9 June 2021."},{"key":"4769_CR31","doi-asserted-by":"crossref","unstructured":"Riley M, Lambrelli D, Graham S, Henry O, Sutherland A, Schmidt A, et al. Facilitating safety evaluation in maternal immunization trials: A retrospective cohort study to assess adverse infant outcomes following low-risk pregnancies in England. BMC Pregnancy Childbirth. 2021 (Submitted for publication).","DOI":"10.1186\/s12884-022-04769-x"},{"issue":"3","key":"4769_CR32","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ije\/dyv098","volume":"44","author":"E Herrett","year":"2015","unstructured":"Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, van Staa T, et al. Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015;44(3):827\u201336.","journal-title":"Int J Epidemiol"},{"key":"4769_CR33","unstructured":"Clinical Practice Research Datalink (CPRD). Pregnancy Register and Mother-baby link. https:\/\/cprd.com\/linked-data#Mother-baby%20link%20and%20Pregnancy%20Register. Accessed 9 June 2021."},{"issue":"7","key":"4769_CR34","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/14760584.2020.1791092","volume":"19","author":"W Kandeil","year":"2020","unstructured":"Kandeil W, van den Ende C, Bunge EM, Jenkins VA, Ceregido MA, Guignard A. A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis. Expert Rev Vaccines. 2020;19(7):621\u201338.","journal-title":"Expert Rev Vaccines"},{"issue":"49","key":"4769_CR35","doi-asserted-by":"publisher","first-page":"5993","DOI":"10.1016\/j.vaccine.2016.07.006","volume":"34","author":"J Bonhoeffer","year":"2016","unstructured":"Bonhoeffer J, Kochhar S, Hirschfeld S, Heath PT, Jones CE, Bauwens J, et al. Global alignment of immunization safety assessment in pregnancy - The GAIA project. Vaccine. 2016;34(49):5993\u20137.","journal-title":"Vaccine"},{"issue":"49","key":"4769_CR36","doi-asserted-by":"publisher","first-page":"6007","DOI":"10.1016\/j.vaccine.2016.07.007","volume":"34","author":"CE Jones","year":"2016","unstructured":"Jones CE, Munoz FM, Kochhar S, Vergnano S, Cutland CL, Steinhoff M, et al. Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy. Vaccine. 2016;34(49):6007\u201314.","journal-title":"Vaccine"},{"issue":"1","key":"4769_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","volume":"73","author":"KY Liang","year":"1986","unstructured":"Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73(1):13\u201322.","journal-title":"Biometrika"},{"key":"4769_CR38","unstructured":"Office for National Statistics. Births in England and Wales: 2017. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/livebirths\/bulletins\/birthsummarytablesenglandandwales\/2017. Accessed 9 June 2021."},{"key":"4769_CR39","unstructured":"National Health Service. Miscarriage. https:\/\/www.nhs.uk\/conditions\/miscarriage\/. Accessed 9 June 2021."},{"key":"4769_CR40","unstructured":"National Institute for Health and Care Excellence. Preterm labour and birth: NICE guideline [NG25]. https:\/\/www.nice.org.uk\/guidance\/ng25\/resources\/preterm-labour-and-birth-pdf-1837333576645. Accessed 9 June 2021."},{"key":"4769_CR41","unstructured":"Office for National Statistics. Conception and fertility rates. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/conceptionandfertilityrates. Accessed 9 June 2021."},{"key":"4769_CR42","unstructured":"Clinical Practice Research Datalink (CPRD). https:\/\/cprd.com\/home. Accessed 9 June 2021."},{"key":"4769_CR43","doi-asserted-by":"crossref","unstructured":"Kendle AM, Salemi JL, Tanner JP, Louis JM. Delivery-associated sepsis: trends in prevalence and mortality. Am J Obstet Gynecol. 2019;220(4):391.e1\u201316.","DOI":"10.1016\/j.ajog.2019.02.002"},{"issue":"1","key":"4769_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009494","volume":"6","author":"SJ Coton","year":"2016","unstructured":"Coton SJ, Nazareth I, Petersen I. A cohort study of trends in the prevalence of pregestational diabetes in pregnancy recorded in UK general practice between 1995 and 2012. BMJ Open. 2016;6(1): e009494.","journal-title":"BMJ Open"},{"issue":"86","key":"4769_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20860","volume":"20","author":"D Farrar","year":"2016","unstructured":"Farrar D, Simmonds M, Griffin S, Duarte A, Lawlor DA, Sculpher M, et al. The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation. Health Technol Assess. 2016;20(86):1\u2013348.","journal-title":"Health Technol Assess"},{"key":"4769_CR46","unstructured":"National Health Service England. Improving outcomes for patients with sepsis. https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2015\/08\/Sepsis-Action-Plan-23.12.15-v1.pdf. Accessed 9 June 2021."},{"issue":"6","key":"4769_CR47","doi-asserted-by":"publisher","first-page":"654.e1","DOI":"10.1016\/j.ajog.2010.04.006","volume":"202","author":"DR Coustan","year":"2010","unstructured":"Coustan DR, Lowe LP, Metzger BE, Dyer AR. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: paving the way for new diagnostic criteria for gestational diabetes mellitus. Am J Obstet Gynecol. 2010;202(6):654.e1-6.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"4769_CR48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/1742271X18760657","volume":"26","author":"M Williams","year":"2018","unstructured":"Williams M, Turner S, Butler E, Gardosi J. Fetal growth surveillance - Current guidelines, practices and challenges. Ultrasound. 2018;26(2):69\u201379.","journal-title":"Ultrasound"},{"issue":"4","key":"4769_CR49","first-page":"516","volume":"23","author":"S Clifford","year":"2013","unstructured":"Clifford S, Giddings S, Southam M, Williams M, Gardosi J. The Growth Assessment Protocol: a national programme to improve patient safety in maternity care. Midwifery Digest. 2013;23(4):516\u201323.","journal-title":"Midwifery Digest"},{"key":"4769_CR50","unstructured":"Royal College of Obstetricians and Gynaecologists. Small-for-Gestational-Age Fetus, Investigation and Management (Green-top Guideline No. 31). https:\/\/www.rcog.org.uk\/en\/guidelines-research-services\/guidelines\/gtg31\/. Accessed 9 June 2021."},{"key":"4769_CR51","unstructured":"Office for National Statistics. Populations by sex, age group and Index of Multiple Deprivation (IMD) quintile, England, 2001 to 2017. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationestimates\/adhocs\/009283populationsbysexagegroupandimdquintileengland2001to2017. Accessed 9 June 2021."},{"issue":"8","key":"4769_CR52","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017474","volume":"7","author":"F Nissen","year":"2017","unstructured":"Nissen F, Morales DR, Mullerova H, Smeeth L, Douglas IJ, Quint JK. Validation of asthma recording in the Clinical Practice Research Datalink (CPRD). BMJ Open. 2017;7(8): e017474.","journal-title":"BMJ Open"},{"issue":"7","key":"4769_CR53","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-005540","volume":"4","author":"JK Quint","year":"2014","unstructured":"Quint JK, M\u00fcllerova H, DiSantostefano RL, Forbes H, Eaton S, Hurst JR, et al. Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD). BMJ Open. 2014;4(7): e005540.","journal-title":"BMJ Open"},{"issue":"2","key":"4769_CR54","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/pds.5150","volume":"30","author":"A Arana","year":"2021","unstructured":"Arana A, Margulis AV, Varas-Lorenzo C, Bui CL, Gilsenan A, McQuay LJ, et al. Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom. Pharmacoepidemiol Drug Saf. 2021;30(2):237\u201347.","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-04769-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-022-04769-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-04769-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T22:45:57Z","timestamp":1675723557000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-022-04769-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4769"],"URL":"https:\/\/doi.org\/10.1186\/s12884-022-04769-x","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]},"assertion":[{"value":"3 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CPRD obtained ethics approval to receive and supply patient data for public health research (ExternalRef removed). The protocol of this retrospective observational cohort study was approved by the Independent Scientific Advisory Committee (ISAC) for research involving CPRD data (protocol no. 18_144RA) and has been made available to the journal reviewers. All methods were carried out in accordance with relevant guidelines and regulations. As per CPRD process (ExternalRef removed), no information that can identify a patient is ever sent to CPRD; CPRD never receives any patient identifiers from a GP practice such as patient name, address, NHS number, full date of birth or medical notes; and because a patient cannot be identified from data a GP practice sends to CPRD, ISAC does not require the GP practice to seek a patient\u2019s consent to share data with CPRD. This study is based on data from the CPRD obtained under license from the UK Medicines and Healthcare products Regulatory Agency. The data are provided by patients and collected by the National Health Service as part of their care and support. The interpretation and conclusions contained in this report are those of the authors alone.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MR and OH are employees of the GSK group of companies (GSK). ASc, ASu, and SS were GSK employees at the time of the study. OH, ASc, and SS own GSK stocks or shares. DL, NSL, RD, and SG are salaried employees of Evidera, the consultancy company hired by GSK to perform this work. The authors declare no other financial or non-financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"461"}}